Analytical Chemistry and Pharmaceutical Technology, Vrije Universiteit Brussel-VUB, Laarbeeklaan 103, 1090 Brussels, Belgium.
Anal Chim Acta. 2009 Dec 10;656(1-2):85-92. doi: 10.1016/j.aca.2009.10.013. Epub 2009 Oct 31.
The use of dissimilar chromatographic systems in drug impurity profiling can be very advantageous. Screening a new-drug impurity mixture on those systems not only enhances the chance that all impurities are revealed, but also allows choosing a suited system for further method development. In this paper several strategies were evaluated to predict the optimal pH (of the buffer used in the mobile phase) from the screening results. Four or five dissimilar stationary phases were screened at four pH values (between 2.5 and 9.4), in order to obtain maximal information about the composition of the sample and to select one column for the subsequent optimization. Different linear models (straight lines, 2nd and 3rd degree polynomials) based on these experiments were tested for their ability to predict the retention times (t(R)) of the impurities at intermediate pH values. The predicted t(R) values were then used to calculate minimal resolutions and eventually to select an optimal pH at which the highest minimal resolution is predicted. None of the applied models is accurate enough to predict correctly which peaks are worst separated at the indicated optimal pH. However, the best strategy (applying a second degree polynomial describing the t(R) measured at 3 consecutive screening pH values) did succeed in indicating an optimal pH at which a good separation of the impurities is obtained. Unfortunately, the resulting separation quality is not or only slightly better than the best separation obtained during screening. Therefore, it can be concluded that the most (time-) efficient approach to develop an impurity profile of a new drug is to screen it on four or five dissimilar columns at four different pH values and to retain the best screening conditions (without making predictions for intermediate conditions) for further optimization of the organic modifier composition of the mobile phase, and occasionally the temperature and the gradient. This is at least the case when the profiles have a complexity similar to those studied.
在药物杂质剖析中使用不同的色谱系统可能非常有利。在这些系统上筛选新药杂质混合物不仅增加了揭示所有杂质的机会,而且还可以选择适合的系统进行进一步的方法开发。在本文中,评估了几种策略来根据筛选结果预测最佳 pH 值(用于流动相的缓冲液的 pH 值)。在四个 pH 值(2.5 至 9.4 之间)下筛选了四个或五个不同的固定相,以便获得有关样品组成的最大信息,并选择一个用于后续优化的柱子。基于这些实验,测试了不同的线性模型(直线、二次和三次多项式),以评估其预测杂质在中间 pH 值下保留时间(t(R))的能力。然后使用预测的 t(R)值计算最小分辨率,并最终选择预测最高最小分辨率的最佳 pH 值。应用的模型都不够准确,无法正确预测在指示的最佳 pH 值下哪些峰的分离效果最差。然而,最佳策略(应用描述在 3 个连续筛选 pH 值下测量的 t(R)的二次多项式)确实成功地指示了一个最佳 pH 值,在该 pH 值下可以获得杂质的良好分离。不幸的是,得到的分离质量并不比筛选过程中获得的最佳分离质量好或仅略有改善。因此,可以得出结论,开发新药杂质谱的最有效(时间)方法是在四个或五个不同 pH 值下对其进行筛选,保留最佳筛选条件(不预测中间条件),以进一步优化流动相有机改性剂组成,并偶尔优化温度和梯度。当谱图的复杂性与所研究的谱图相似时,情况尤其如此。